ANAKA PHARMA Trademark

Trademark Overview


On Monday, April 7, 2025, a trademark application was filed for ANAKA PHARMA with the United States Patent and Trademark Office. The USPTO has given the ANAKA PHARMA trademark a serial number of 99123382. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, April 7, 2025. This trademark is owned by Anaka Pharmaceuticals, Inc.. The ANAKA PHARMA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Small molecule therapeutic preparations for the treatment of neurodevelopment disorders, including attention deficit hyperactivity disorder (ADHD), autism spectrum disorders, and Down syndrome

Pharmaceutical research and development for neurodevelopment disorders
anaka pharma

General Information


Serial Number99123382
Word MarkANAKA PHARMA
Filing DateMonday, April 7, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, April 7, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing0 - NOT AVAILABLE
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of figures representing molecular models positioned at the top left of the wording "anaka pharma." The first molecular model consists of three purple circles of varying sizes connected by lines. The second model includes three blue circles of different sizes, also connected by lines. The third model has two orange circles of varying sizes connected by a line, with a small purple circle positioned above the figure. The wording "anaka" is in stylized, bold, lower-case black letters, and the wording "pharma" is in smaller, stylized, bold, and thinner lower-case black letters beneath it. The white in the mark is background and is not part of the mark.
Goods and ServicesSmall molecule therapeutic preparations for the treatment of neurodevelopment disorders, including attention deficit hyperactivity disorder (ADHD), autism spectrum disorders, and Down syndrome
Indication of Colors claimedThe color(s) purple, blue, orange, and black is/are claimed as a feature of the mark.
Goods and ServicesPharmaceutical research and development for neurodevelopment disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 7, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 7, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAnaka Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02420

Trademark Events


Event DateEvent Description
Monday, April 7, 2025NEW APPLICATION ENTERED
Monday, April 7, 2025APPLICATION FILING RECEIPT MAILED